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Abstract Aims: Our objectives were, first, to study seasonal distribution of perioperative deaths within 30
days after surgery, and late death, in children undergoing surgery for congenitally malformed hearts, and
second, to study the causes of late death. Methods: We analysed a retrospective cohort of 1,753 children with
congenital cardiac malformations born and undergoing surgery in the period from 1990 through 2002 with a
special focus on the causes of late death. The data was obtained from the registry of congenital cardiac
malformations at Rikshospitalet, Oslo, and the Norwegian Medical Birth Registry. The mean follow-up from
birth was 8.1 years, with a range from zero to 15.2 years. Results: During the period of follow-up, 204
(11.6%) of the children died having undergone previous surgery. Of these 124 (7.1%) died in the
perioperative period, and 80 (4.5%) were late deaths. There were 56 late deaths during the 6 coldest months,
compared with 24 during the 6 warmest months (p, 0.01). There was no significant seasonal variation in
perioperative deaths. Respiratory infection was the most common cause of late death, and occurred in 25
children, of whom 24 died during the 6 coldest months. Of the 8 sudden late deaths, 7 occurred during the
6 coldest months. There was no seasonal variation for the other causes of death. Conclusions: In children
undergoing surgery for congenital cardiac malformations in Norway, there is a seasonal variation in late death,
with a higher proportion occurring in the coldest months. Death related to respiratory infections
predominantly occurs in the winter season, and is the overall most common cause of late death.
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D
URING THE LAST DECADE, SEVERAL STUDIES HAVE
identified a significant decrease in peri-
operative mortality among children under-
going surgery for congenital cardiac malformations.1–5
In many surgical centres, data is available only for the
first 30 postoperative days, and this data is commonly
used to document the quality of the care.4,6–11
Mortality after the first 30 postoperative days,
nonetheless, is still significant,3,12–14 and is related
to other factors than those responsible for early death.
Previous studies have focused on the cause of death in
adults with congenital cardiac malformations,15
sudden death,16 and on cause of death in patients
with specific cardiac conditions.17–21
The aim of our present study was to investigate
the seasonal distribution of early and late death, and
the causes of late death, in 1,753 children born
in the period from 1990 through 2002 who under-
went surgery for congenital cardiac malformations
at Rikshospitalet, Oslo, Norway. During this
period, this centre served as a tertiary centre for
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three-quarters of all children in Norway with con-
genital cardiac malformations. Detailed clinical
information is presented for children who survived
the first 30 days after surgery, but subsequently died.
Material and methods
Design
The study is a population-based, retrospective cohort
study based on a registry of congenital cardiac
malformations.
Sources of data
The registry of congenital cardiac malformations
at the Department of Paediatric Cardiology at
Rikshospitalet, Oslo, Norway, was used to identify
the children suitable for inclusion in the study. The
registry contains data on diagnosis, interventions,
surgery, and detailed clinical outcome extracted from
hospital journals, autopsy reports, as well as infor-
mation from other hospitals, out-patient clinics, and
local doctors. Identification of patients is based on
the unique personal identification number from the
National Population Registry, which also provides
information on date of death or emigration. These
data were merged with data from the Norwegian
Medical Birth Registry, which includes data on
causes of death in children who died the first year
of life.
Population
Surgeons at the Rikshospitalet performed 75% of
all the cardiac surgical procedures in children in
Norway during the period of study. The birth rate
in the source population was approximately 45,000
per year over this period. The population identified
for inclusion in the study consists of 1,753 liveborn
children undergoing surgery for congenital cardiac
malformations at Rikshospitalet between January 1,
1990, and September 1, 2002. Only children who
underwent open or closed cardiac surgery related to
palliation or anatomical correction of structural
cardiac defects were included. Children who only
underwent procedures as implantation of pacemakers,
pericardial drainage, or extracorporeal membrane
oxygenation were excluded, as well as children who
were treated only with catheter-based interventions.
Children with acquired heart disease, arrhythmias,
cardiomyopathy, and positional anomalies were
excluded from the study if they did not also undergo
surgery for structural congenital cardiac defects. Also
excluded were 33 children undergoing surgery
abroad, and 108 premature infants who underwent
surgical closure of persistently patent arterial ducts
before the age of two months. Excluding re-opera-
tions within 30 days, a total of 2,246 cardiac operations
were performed in the population studied during
this period.
Data regarding death and emigration was 99%
complete for the population on March 1, 2005. For
the children who died in the period between Sept.
1, 2002 and March 1, 2005, data regarding surgery
and cause of death was updated and included in the
analysis.
Variables
Cardiac malformations. Classification of cardiac
malformations was based on results from echo-
cardiographic examinations, cardiac catheterisations,
and in some instances from findings at surgery or
autopsy. The conditions were coded both according to
the classification system developed by Van Mierop22,23
and the 10th edition of the International Classification
of Diseases. Based on previous epidemiologic classi-
fications,24,25 the cardiac malformations were assigned
into the following three groups:
> The functionally univentricular arrangement
included children registered with hypoplastic
left heart syndrome, functionally univentricular
physiology, and tricuspid atresia, in whom
Fontan palliation was regarded as the ultimate
surgical option.
> The group of severe cardiac defects included
children with the following 9 conditions: atrioven-
tricular septal defects, concordant atrioventricular
and discordant ventriculo-arterial connections, or
transposition, double outlet right ventricle, tetra-
logy of Fallot, totally anomalous pulmonary
venous connection, pulmonary atresia with intact
ventricular septum, interrupted aortic arch, com-
mon arterial trunk, and Ebstein’s malformation.
> The groups of less severe cardiac defects included
children with other cardiac defects than those
placed in the first two groups.
In addition, each child who died was given a
principal diagnosis based on the morphologically
and/or hemodynamically most important lesions
determined by the consensus of two paediatric
cardiologists.
Extra-cardiac anomalies. Significant extra-cardiac
congenital malformations and syndromes recorded
in the registry of congenital cardiac malforma-
tions were included in the analysis. Minor anomalies,
such as syndactyly of fingers or toes, isolated vascular
anomalies of the skin, congenital pigmented
naevuses, and congenital dislocation of the hip are
examples of anomalies not entered into the registry.
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In 5 children who died, 3 in the perioperative period
and 2 late, extra-cardiac anomalies were recorded in
the data on causes of death from Norwegian Medical
Birth Registry, but not in the registry of congenital
cardiac malformations. These data were included in
the analysis.
The children were assigned into three groups
based on the presence or absence of extra-cardiac
anomalies. In the first group there were children
with no extra-cardiac anomalies. Allocated to the
second group were children with Down’s syn-
drome, provided that Down’s syndrome was the only
extra-cardiac anomaly. Patients with extra-cardiac
anomalies other than Down’s syndrome formed the
third group.
Seasons. According to the Norwegian Meteo-
rological Institute, the six coldest months in Norway
are November through April. This period was
defined as the winter season, and the months May
through October as the summer season.
Cause of death. Perioperative death was defined
as death within 30 days after cardiac surgery. Late
death was defined as death later than 30 days after
cardiac surgery. In addition, those children who
died before discharge from hospital after cardiac
surgery, but more than 30 days after the operation,
were included as late deaths. Based on the available
data, the cause of late deaths was determined by the
consensus of two paediatric cardiologists (Eskedal
and Thaulow). In children who died outside
hospital without having an autopsy performed,
information from primary health care centres and
local doctors was used to determine the cause of
death. Six categories of late death were defined:
> The group with respiratory infection included
children diagnosed with infections in the upper
or lower respiratory tract.
> The group with non-respiratory infection inclu-
ded children with the diagnoses of septicaemia,
gastroenteritis, and unspecified viral infection
(International Classification of Diseases, 9th
edition: 079.9).
Children in these first two categories included
those who died in hospital who were diagnosed with
infection during the final hospital admission, those
with diagnosed infection at autopsy, and those with
infection diagnosed outside hospital the during the
last 7 days of life.
> The category of sudden death included children
with unexpected instantaneous death, or death
within 24 hours after the onset of acute
symptoms or signs (International Classification
of Diseases, 9th edition: 798, International
Classification of Diseases, 10th edition: R96).
> The group of procedure related deaths included
children who died as a consequence of cardiac
catheterisation or non-cardiac surgical proce-
dures.
> The group of those with other non-cardiac deaths
included children with trisomy 13, Werdnig-
Hoffman disease, and children who died from an
external cause of injury or from malignant
disease.
> The final group of cardiovascular death included
all those children not allocated to one of the
other five categories, which also contained
children who died due to progressive myocardial
failure or nonsudden death secondary to arrhy-
thmia.
Statistical analyses. Frequencies and percentages
were used to summarize the data. Cross tabulation
with p values from Pearson x2 tests plus odds ratios
as a measure of effect size were used. Version 13.0 of
the Statistical Product and Service Solutions was
used in the calculations. A p value less than 0.05
was considered statistically significant.
Ethical considerations. The study was approved by
the Regional Committee for Medical Research, the
Norwegian Data Inspectorate, and the Norwegian
Directorate of Health and Social Services.
Results
Of the children included, 141 (8%) had a function-
ally univentricular arrangement, 641 (36.6%) had
severe cardiac defects and 971 (55.4%) had less severe
cardiac defects. Down’s syndrome was registered in
209 children (11.9%), and extra-cardiac anomalies
other than Down’s syndrome in 197 (11.2%). Of the
children with Downs’s syndrome, 9 had additional
extra-cardiac anomalies. Of the 1,753 children
undergoing surgery, 204 (11.6%) died during
follow-up, with 124 (7.1%) dying in the periopera-
tive period, and 80 (4.5%) late deaths. Age at initial
cardiac surgery was less than 1 month in 29% of the
children, and less than 12 months in 70%. Mean
follow-up from birth was 8.1 years, with a range
from zero to 15.2 years.
Of the children with the functionally uni-
ventricular arrangement, 36 (26%) died in the
perioperative period, and 14 (10%) died subse-
quently. Of children with severe cardiac defects, 60
(9%) died in the perioperative period, and 39 (6%)
subsequently. In children with less severe cardiac
defects, there were 28 perioperative (3%) deaths,
and 27 (3%) late deaths. Death in the perioperative
period occurred in 10 (5%) children with Down’s
syndrome, and late deaths in 14 (7%) children.
Children with extra-cardiac anomalies other than
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Down’s syndrome suffered 17 (7%) perioperative
deaths, and 20 (10%) late deaths. Gender was
evenly distributed in children who died in the
perioperative period, with 63 males and 61 females.
Seasonal distribution of deaths
Of the total number of cardiac operations, excluding
reoperations performed within 30 days, 1,097
(48.8%) were performed during the winter season.
The month of birth was evenly distributed in the
cohort, with 882 (50.4%) born in winter season.
In Figure 1, we show perioperative and late
deaths occurring during the winter and summer
season. There was no significant difference in
seasonal distribution of perioperative deaths. There
were, however, significantly more late deaths during
the winter season (p, 0.001). Excluding periopera-
tive deaths, the children remaining at risk of late
death were equally distributed regarding season of
birth, with 815 (50%) born in winter season.
Causes of late death
Cause of death could be determined in 78 of the 80
children dying late. Autopsy was performed in 41
children with late deaths, with 9 children dying
outside hospital not submitted to autopsy.
In Figure 2, we show the seasonal distribution
of the causes of death in the 78 children dying
late. The cause of death was more likely to be a
respiratory infection if death occurred during winter
season compared with death occurring during
summer season, with an odds ratio of 17.3, and
95% confidence intervals from 2.2 to 137, giving a
p value of less than 0.01. The odds ratio for the
cause of death to be an infection, be it respiratory or
non-respiratory, was 3.3 for children who died
in the winter season compared with children who
died in the summer season, with 95% confidence
intervals from 1.2 to 9.0, and p equal to 0.02.
There were 7 children who died suddenly in the
winter, and only one in the summer season. Autopsy
was performed in only 2 of these 8 children. Of 8
sudden deaths registered, 4 occurred before the age
of one year. In 3 of the 8, there was a functional
univentricular arrangement palliated with a central
shunt, 2 had double outlet right ventricle, 1 had
an atrioventricular septal defect, 1 had Ebstein’s
malformation, and 1 one had an atrial septal defect
in the setting of Down’s syndrome. Of the children
who died suddenly in the winter season, 3 were
recovering after a respiratory infection.
The 20 cardiovascular deaths were evenly
distributed in regard to season. There were 4
children who died before discharge from hospital,
14 died in hospital after re-admission, and 2 died
outside hospital, with 3 children with Down’s
syndrome, and 4 having extra-cardiac anomalies
other than Down’s syndrome. Persistent pulmonary
hypertension was registered in 5 children, and
arrhythmias in 4 children. There were 4 children
with a functionally univentricular arrangement, 7
had severe cardiac defects, and 9 had less severe
cardiac defects. The principal cardiac diagnoses for
the 9 children with less severe cardiac defects were
coarctation of the aorta and ventricular septal defect
in 3, coarctation of the aorta in 2, congenitally
corrected transposition, tetralogy of Fallot with
Figure 1.
Seasonal distribution of perioperative deaths and late deaths in
children undergoing surgery for congenital cardiac malformations.
Figure 2.
Seasonal distribution of causes of late death in children undergoing
surgery for congenital cardiac malformations. * Cause of death
unknown in one child who died in winter season and in one child
who died in summer season.
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pulmonary atresia, valvar aortic stenosis, and
ventricular septal defect.
The 5 procedurally related deaths included 2
children who died during cardiac catheterisa-
tion, and 3 who died during non-cardiac surgical
procedures. The 6 non-cardiac causes of death were
due to trisomy 13 in 2, Werdnig Hoffmann disease,
multiple non-cardiac anomalies, external accident,
and one death due to malignancy. The principal
cardiac diagnosis in the children who died from
non-cardiac causes were atrial septal defect in 2,
ventricular septal defect in 2, and one each with
tetralogy of Fallot with pulmonary stenosis and
with pulmonary atresia.
In Table 1, we list the clinical diagnoses and
aetiological agents in children who died with an
infection. Among 25 children who died of a respi-
ratory infection, only one died during the summer
season, this being diagnosed as an unspecified
respiratory infection.
There were 5 children who died in hospital
subsequent to infection by the respiratory syncytial
virus. All died before the age of two years, with
4 of the 5 dying before they were one year old.
Of these, 3 had a severe cardiac defect, and one
had a functionally univentricular arrangement.
Another child had pulmonary hypertension,
and 3 were cyanotic before acquiring the viral
infection. None had received prophylaxis with
palivizumab.
In the 14 children who died with a non-
respiratory infection, 6 died in the summer season,
5 with a clinical diagnosis of septicaemia, and one
with unspecified viral infection.
None of the children who died with an infection
were coded with influenzal infection according to
International Classification of Diseases, 9th or 10th
edition.
In Table 2, we show the distribution of cardiac
defects and associated non-cardiac anomalies in all
children dying late, and in the children who died
with a respiratory or non-respiratory infection. In
children who died from a respiratory infection,
one-third had Down’s syndrome. We compared the
10 children with Down’s syndrome who either died
in the perioperative period, the 14 dying late, and
the 185 who survived, finding no differences in
distribution of gender, gestational age, birth weight
or age at initial cardiac surgery.
In Table 3, we show gender, survival-time after
last cardiac surgery, age at time of death and place of
death for all children dying late, and for children
who died with an associated infection. Gender and
survival-time after last cardiac surgery were evenly
distributed in the 3 categories of late death. The
majority of all late deaths occurred before the
children were two years old, and 44 (55%) children
died before the age of one year. The group with
respiratory infections had the highest proportion of
deaths during the first two years of life, with 80%
of deaths occurring before the age of 2 years.
Survival after the last cardiac surgery was short,
with a median survival in the range from 4 to 6
months in all 3 groups.
Table 1. Clinical diagnosis and etiologic agent in children who died related to infections.
Clinical diagnosis Etiologic agent
n n
Respiratory infection (n5 25)
Pneumonia 6 Respiratory syncytial virus1 1
Klebsiella pneumoniae2 1
Bronchopneumonia 5 Staphylococcus aureus and Acinetobacter sp2 1
Streptococcus pneumoniae2 1
Bronchiolitis 5 Respiratory syncytial virus1 4
Pharyngitis 2
Tonsilitis 1
Unspecified respiratory infection 6 Streptococcus pneumoniae3 1
Non-respiratory infection (n5 14)
Septicaemia 11 Streptococcus pneumoniae3 1
Gram positive coccus3 1
Coagulase negative staphylococcus3 2
Coagulase negative staphylococcus and Gram positive coccus3 1
Gastroenteritis 2 Rotavirus4 1
Unspecified viral infection 1
1: Respiratory syncytial virus detected in nasopharyngeal secretions.
2: Isolated from lungs at autopsy.
3: Isolated in blood culture.
4: Detected in faeces.
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Table 2. Cardiac malformations and associated extra-cardiac anomalies in all late deaths and in children who died related to infections.
All late deaths
(n5 80)
Respiratory infection
(n5 25)
Non-respiratory infection
(n5 14)
n (%) n n
Cardiac defect
Functionally univentricular arrangement 14 (18%) 2 5
Double inlet ventricle or AV atresia 11 1 4
Hypoplastic left heart syndrome 3 1 1
Severe cardiac defects 39 (49%) 17 7
Atrioventricular septal defect 14 9 2
Tetralogy of Fallot 7 3 1
Double outlet right ventricle 5 2
Transposition 4 1 1
Pulmonary atresia with intact ventricular septum 3 1
Common arterial trunk 3 1 2
Ebstein’s malformation 2
Interrupted Aortic arch 1 1
Less severe cardiac defects 27 (34%) 6 2
Ventricular septal defect 6 3
Tetralogy with pulmonary atresia 4 1 1
Coarction of the aorta and VSD 3
Coarction of the aorta 3 1
Aortic stenosis 3 1
Congenitally corrected transposition 3
Atrial septal defect 3
Anomaly of Coronary Artery 1 1
Double Aortic arch 1
Associated non-cardiac anomalies
No associated anomalies 46 (58%) 12 7
Down’s syndrome 14 (18%) 8 2
Associated anomaly other than Down’s 20 (25%) 5 5
Asplenia 4 2
Multiple malformations, unclassified 3 1
Gastrointestinal malformation 3 1
Trisomy 13 2
VACTERL syndrome 1 1
DiGeorge syndrome 1 1
Malformation of central nervous system 1 1
Cleft lip/palate 1 1
Werdnig-Hoffmann disease 1
Apert’s syndrome 1
Noonan syndrome 1 1
Rubinstein-Taby syndrome 1 1
AV5 atrioventricular, VSD5 ventricular septal defect.
Table 3. Gender, survival time after surgery, age and place of death in all late deaths and in children who died related to infections.
All late deaths
(n5 80)
Respiratory
infection (n5 25)
Non-respiratory
infection (n5 14)
Gender (male/female) 41/39 12/13 9/5
Survival time after last cardiac surgery (months; median, (range)) 5.8 (1.1–120) 4.8 (1.5–106) 4.5 (1.1–39)
Age at death (months; median, (range)) 10.8 (1.6–142) 8.8 (2.6–125) 12.1 (1.6–53)
Age, 2 years (n, (%)) 58 (73%) 20 10
Death in hospital, before discharge after surgery (n, (%)) 11 (14%) 0 3
Death in hospital, re-admission (n, (%)) 49 (61%) 20 9
Death during transportation or within 1 hour after arrival at
emergency department (n, (%))
5 (6%) 1 1
Death outside hospital (n, (%)) 15 (19%) 4 1
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Late deaths before discharge from hospital after
cardiac surgery
There were 11 children who died in the range of 34
to 90 days after the last operation, and 9 of them
died before 1 year of age, with 6 dying in the winter
season. The causes of death in these 11 children
were septicaemia in 2, gastroenteritis in 1, death
during cardiac catheterisation for 2, sudden death
in 1, Werdnig Hoffmann disease in 1, and the final
4 deaths due to progressive cardiac failure. Associated
non-cardiac anomalies were found in 5 of the 11
children, with 2 having Down’s syndrome. The
cardiac diagnosis was a functionally univentricular
arrangement in 3, atrioventricular septal defect in 3,
aortic stenosis in 2, coarctation of the aorta in 2, and
ventricular septal defect in the final child.
Discussion
In this study, we present data on the deaths of
children undergoing surgery for cardiac malforma-
tions as based on follow-up information we hold on
children born in Norway between 1990 to 2002.
Late deaths after surgery accounted for two-fifths of
all deaths occurring in our cohort of patients. We
found that such late death was more than two times
more likely to occur during the winter season than
in the summer season. Excluding perioperative
deaths, the children left at risk of late death showed
no seasonal variation in season of birth or season of
cardiac surgery that could influence the seasonal
distribution of late deaths. Of the 11 children who
died before discharge from hospital, but later than
30 days after surgery, 6 died during the winter
season. Reclassification of these children to the
group of those dying in the perioperative period had
no impact on our conclusions.
There was a clear seasonal difference in causes of
late death, especially respiratory infections, which
were significantly more common as a cause of death
during the winter period. It is difficult to be
completely sure, in retrospect, about the leading
cause of death. We found a striking seasonal
difference, nonetheless, in the occurrence of late
deaths, and this finding seems to be associated with
the higher proportion of deaths caused by respira-
tory infections deaths during the winter season. Our
data does not contain detailed information of how
many children who survived respiratory infections
throughout the year, and the risk of death due to a
respiratory infection cannot be estimated. We also
have to take account that the climate in Norway,
with low temperatures in the winter months, might
be a risk factor of death in itself in children with
limited cardiac reserves. If so, the impact of season
on mortality would be greater in countries with
cold winters as compared with countries with mild
climate throughout the year.
The impact of respiratory infection has been
described both in adults26,27 and children with
cardiac disease.28,29 In agreement with the present
results, it has been documented in studies from
national health registries that infection with both
the influenza and respiratory syncytial viruses are
major contributors to deaths and morbidity in
children in general.30–32 It is also known that
children with cardiac malformations are at parti-
cular risk of serious infection by the respiratory
syncytial virus.29,32–34 In our study, only 5 of the 25
children who died from a respiratory infection had a
verified infection with the respiratory syncytial
virus. Since our data is obtained retrospectively, this
number is probably too low, especially when taking
account of the high prevalence of infection by the
respiratory syncytial virus in hospitalised children
under the age of one year in general.32 There are
several recent publications on the safety, efficacy and
economic implication of prophylaxis with palivizu-
mab in children with cardiac malformations.35–40
Palivizumab has been used for prophylaxis in a few
children with cardiac malformations in Norway
since 1999, but our period of study is mainly from
the time before palivizumab was introduced.
Immunisation with palivizumab has, in one trial,
been shown to be effective in reducing hospitalisa-
tion caused by respiratory syncytial virus in children
with cardiac malformations, but mortality was
not significantly reduced.40 Also important is that
this trial enrolled only children with unoperated
or partially corrected cardiac defects in a stable
condition, and with no associated non-cardiac
anomalies. We observe that in our cohort of children
undergoing cardiac surgery, more than half of the
children who died with an associated respiratory
infection after the immediate postoperative period
had associated non-cardiac anomalies.
It proved possible to isolate Streptococcus pneumonia
in 3 children who died. In Norway, vaccination
against pneumococcal disease was not routinely
performed during the period of study unless there
was also an accompanying immune defect. Our
study did not identify any late deaths with a
terminal infection due to influenza virus. This
might be because of the limitations of our
retrospective data.
Sudden death occurred in 8 of the 1,629 children
who survived the first 30 days after cardiac surgery.
This is lower than previously reported,16,41 and may
relate to the relatively short follow-up time in our
study. An increased incidence of sudden death
during the winter season has been reported in the
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general population,42–44 which is in agreement with
the present observations. It may be that sub-clinical
infections are of importance for sudden death in
patients with a low cardiovascular reserve, but our
data cannot answer this suggestion.
The complexity of the cardiac malformations was
higher in the group of children dying late, with two
thirds having either severe cardiac defects or a
functionally univentricular arrangement, as com-
pared with 45% in the total population studied.
Furthermore, there was a high prevalence of
associated extra-cardiac anomalies, these being
found in 43% of children dying late, compared to
23% in the total population. This contrasts with the
observations in children who died in the periopera-
tive period, where associated extra-cardiac anomalies
were registered in only 22%. The available data on
extra-cardiac anomalies was more extensive in
children who died than in children who survived
in our study. If excluding extra-cardiac anomalies
exclusively reported in the Norwegian Medical
Birth Registry, the prevalence of extra-cardiac
anomalies in late deaths would still be 40%. Given
the limitations of analysing data culled from a
register, the definite prevalence of extra-cardiac
anomalies is probably higher than we report.
We have previously shown that overall survival
improved in children with congenital cardiac
anomalies born from 1995 to 1999, as compared
to children born from 1990 to 1995, but this did not
include children with extra-cardiac anomalies other
than Down’s syndrome.45 The group of children with
cardiac malformations and associated extra-cardiac
anomalies other than Down’s syndrome accounts for
one-quarter of late deaths, in contrast to just over one-
tenth in the total population, and one-sixth of the
perioperative deaths. Down’s syndrome was registered
more often in those dying late, specifically in just
under one-fifth, compared with just over one-tenth of
the total population. Down’s syndrome was present in
onethird of the children dying late from respiratory
infections. This observation is in agreement with
previous reports, which have shown that respiratory
infections are leading causes of death in children with
cardiac malformations and Down’s syndrome.46,47
Our population is made up of children born in a
decade in which paediatric cardiac surgery has made
great advances in improving perioperative survival,
despite the fact that more children with complex
cardiac defects are undergoing surgery at an ever
younger age.1,3 In our study, the majority of
children dying late were aged less than 2 years,
and over half of these children died before they
reached the age of one year. Survival after the last
cardiac operation was short, with a median time
under 6 months.
In most studies, the judgement of the quality of
care is based on observations obtained during the
first 30 days after surgery.4,6–11 Our study extends
this data, and suggests that children under-
going surgery for complex cardiac malformations
represent a group at high risk during the first two
years of life, particularly when additional extra-cardiac
anomalies are present. Programmes for immunisation,
close follow-up after cardiac surgery, and early
hospitalisation when symptoms are detected of
respiratory infections, might reduce late mortality.
Our retrospective data, nonetheless, does not allow
definite conclusions. Only prospective studies can
provide clear evidence of which measures will be
effective.
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